News
Building a Patchwork Brain to Study Neurological Disease
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains. The authors aim to use this technique to learn more about how brain cancers form, about how genetic alterations in different parts of
Talk on 'Butt Cancer' Tackles Taboo with Humor to Win 2018 Postdoc Slam
A talk about a little-talked-about topic won the top prize at the 2018 Postdoc Slam. Many people do not know that the same virus that causes cervical cancer, human papillomavirus (HPV), can also infect the skin of the anus and lead to anal cancer, said Sona Chowdhury, PhD, a UC San Francisco
Six UCSF Scientists Awarded NIH Grants for High-Risk, High-Reward Research
The National Institutes of Health (NIH) has awarded six NIH Director’s Awards to early-career UC San Francisco scientists – a record number for the University. Recipients of the highly competitive grants were announced Oct. 2 among the 89 awards funded this year by the High-Risk, High-Reward
Present at Creation of Nobel-Winning 'Checkpoint Inhibitor' Therapies, Immunologist Looks to the Future
Twenty-two years ago, the possibility of using immunotherapy to treat cancer was just being demonstrated in mice. Now the therapies are showing dramatic success in thousands of human patients and have just been acknowledged with a Nobel Prize. Researchers at UC San Francisco and elsewhere are
UCSF Health and John Muir Health to Build East Bay Cancer Network
UCSF Health and John Muir Health have signed a letter of intent to develop a cancer network designed to improve prevention, diagnosis and treatment for patients throughout the East Bay. The joint East Bay Cancer Network will include development of distinguished disease-specific treatment
UCSF Receives $20 Million to Study New Tobacco Products
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products (HTPs), which heat tobacco without
Q&A with Mike Rabow, MD, Director of the HDFCCC Symptom Management Service
In the 13 years since Mike Rabow, MD, established the Symptom Management Service at the UCSF Helen Diller Family Comprehensive Cancer Center, with the support of Peter Carroll, MD, Gerri Shields, and the Mount Zion Health Fund, the specialty palliative care program has grown into one of largest in